Effects of Renal Transplantation on Cardiac Morphology and Function Luis Vernaza Hospital, Guayaquil, Ecuador: Kidney Transplant and Morphology and Cardiac Function

Byron Zúñiga Pineda, J. Lara-Terán, Paola Alprecht-Quiroz, Silvia V. Cáceres-Vinueza, Y. Duarte
{"title":"Effects of Renal Transplantation on Cardiac Morphology and Function Luis Vernaza Hospital, Guayaquil, Ecuador: Kidney Transplant and Morphology and Cardiac Function","authors":"Byron Zúñiga Pineda, J. Lara-Terán, Paola Alprecht-Quiroz, Silvia V. Cáceres-Vinueza, Y. Duarte","doi":"10.31487/j.cdd.2020.01.04","DOIUrl":null,"url":null,"abstract":"Introduction: Structural heart disease is a frequent complication of advanced chronic kidney disease and\nthe leading cause of death in patients with renal replacement therapy, mainly in those on dialysis. There is\nsufficient evidence to demonstrate a regression of left ventricular hypertrophy and improvement of\nventricular function after a successful renal transplant. The objective of this study is to describe the\nexperience regarding the effects of renal transplantation on cardiac remodeling and function and thus\ncorroborate with local data the benefits of renal transplantation on the left ventricular mass index (LVMI\ngrs), Left Ventricle Ejection Fraction (LVEF %), Left Atrium Diameter (LAD mm), Left Ventricle Diastolic\nDiameter (LVDD mm), Left Ventricle Systolic Diameter (LVSD mm), Posterior Wall (PW mm) and\nInterventricular Septum (IVS mm).\nMaterials and Methods: This is a quantitative, observational, descriptive and retrospective study. A\ndatabase was constructed whose information was tabulated and subsequently analysed by the statistical\nprogram SPSS 13 to perform the statistical analysis. The results of the nominal variables were expressed in\npercentages and of the numerical variables in average ± standard deviation (SD) and confidence interval.\nThe study included all adults over18 years with a diagnosis of chronic renal failure who underwent renal\ntransplantation at Luis Vernaza Hospital between January 2009 to December 2016 and who had pre and\npost-transplant transthoracic echocardiography.\nResults: Of the 132 adults undergoing renal transplantation, 74 patients who met the inclusion criteria were\nidentified, their average age was 35.2 years DS (+/- 11.7 years), forty-eight patients (64%) were male. All\npatients were dependent on dialysis, whose average time was 5 years and 88% of the population underwent\nintermittent hemodialysis weekly. The pre-transplant and post-transplant echocardiographic measurements\nwere: LVEF (%) 60.89 ± 1,175 vs. 66.81 ± 0.685 (<0.0001); LVMI (grs) 242.54 ± 11.92 vs. 184.62 ± 7,591\n(<0.0001); LAD (mm) 35.9 ± 0.772 vs. 34.8 ± 0.602 (0.215); LVDD (mm) 47.97 ± 0.756 vs. 44.98 ± 0.927\n(0.003); LVDS (mm) 29.85 ± 0.897 vs. 26.68 ± 0.681 (0.004); PW (mm) 11.86 ± 0.270 vs. 10.92 ± 0.208\n(0.002); IVS (mm) 12.12 ± 0.348 vs. 10.95 ± 0.253 (0.002) respectively.\nConclusion: In this study, was observed a favorable overall impact of renal transplantation on the structure\nand function of the heart, with a significant reduction in LVH and LVMI and systolic and diastolic function\nof the left ventricle, thus reducing the risk of associated death to cardiovascular events.","PeriodicalId":196275,"journal":{"name":"Cardiovascular Diseases and Diagnosis","volume":"196 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Diseases and Diagnosis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31487/j.cdd.2020.01.04","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Structural heart disease is a frequent complication of advanced chronic kidney disease and the leading cause of death in patients with renal replacement therapy, mainly in those on dialysis. There is sufficient evidence to demonstrate a regression of left ventricular hypertrophy and improvement of ventricular function after a successful renal transplant. The objective of this study is to describe the experience regarding the effects of renal transplantation on cardiac remodeling and function and thus corroborate with local data the benefits of renal transplantation on the left ventricular mass index (LVMI grs), Left Ventricle Ejection Fraction (LVEF %), Left Atrium Diameter (LAD mm), Left Ventricle Diastolic Diameter (LVDD mm), Left Ventricle Systolic Diameter (LVSD mm), Posterior Wall (PW mm) and Interventricular Septum (IVS mm). Materials and Methods: This is a quantitative, observational, descriptive and retrospective study. A database was constructed whose information was tabulated and subsequently analysed by the statistical program SPSS 13 to perform the statistical analysis. The results of the nominal variables were expressed in percentages and of the numerical variables in average ± standard deviation (SD) and confidence interval. The study included all adults over18 years with a diagnosis of chronic renal failure who underwent renal transplantation at Luis Vernaza Hospital between January 2009 to December 2016 and who had pre and post-transplant transthoracic echocardiography. Results: Of the 132 adults undergoing renal transplantation, 74 patients who met the inclusion criteria were identified, their average age was 35.2 years DS (+/- 11.7 years), forty-eight patients (64%) were male. All patients were dependent on dialysis, whose average time was 5 years and 88% of the population underwent intermittent hemodialysis weekly. The pre-transplant and post-transplant echocardiographic measurements were: LVEF (%) 60.89 ± 1,175 vs. 66.81 ± 0.685 (<0.0001); LVMI (grs) 242.54 ± 11.92 vs. 184.62 ± 7,591 (<0.0001); LAD (mm) 35.9 ± 0.772 vs. 34.8 ± 0.602 (0.215); LVDD (mm) 47.97 ± 0.756 vs. 44.98 ± 0.927 (0.003); LVDS (mm) 29.85 ± 0.897 vs. 26.68 ± 0.681 (0.004); PW (mm) 11.86 ± 0.270 vs. 10.92 ± 0.208 (0.002); IVS (mm) 12.12 ± 0.348 vs. 10.95 ± 0.253 (0.002) respectively. Conclusion: In this study, was observed a favorable overall impact of renal transplantation on the structure and function of the heart, with a significant reduction in LVH and LVMI and systolic and diastolic function of the left ventricle, thus reducing the risk of associated death to cardiovascular events.
肾移植对心脏形态和功能的影响Luis Vernaza医院,瓜亚基尔,厄瓜多尔:肾移植、形态学和心功能
导论:结构性心脏病是晚期慢性肾脏疾病的常见并发症,也是肾替代治疗患者(主要是透析患者)死亡的主要原因。没有足够的证据证明成功肾移植后左心室肥厚的消退和心室功能的改善。本研究的目的是描述关于肾移植对心脏重塑和功能影响的经验,从而用当地数据证实肾移植对左心室质量指数(LVMIgrs)、左心室射血分数(LVEF %)、左心房直径(LAD mm)、左心室舒张直径(LVDD mm)、左心室收缩直径(LVSD mm)、后壁(PW mm)和室间隔(IVS mm)的益处。材料与方法:这是一项定量、观察性、描述性和回顾性研究。构建数据库,将其信息制表,然后使用SPSS 13统计程序进行统计分析。名义变量的结果以百分比表示,数值变量的结果以平均±标准差(SD)和置信区间表示。该研究纳入了2009年1月至2016年12月期间在Luis Vernaza医院接受肾移植并接受移植前后经胸超声心动图检查的所有诊断为慢性肾衰竭的18岁以上成年人。结果:132例成人肾移植患者中,74例符合纳入标准,平均年龄35.2岁(±11.7岁),男性48例(64%)。所有患者均依赖透析,平均时间为5年,88%的患者每周进行间歇性血液透析。移植前和移植后超声心动图测量:LVEF(%) 60.89±1175 vs 66.81±0.685 (<0.0001);LVMI (grs) 242.54±11.92 vs. 184.62±7591 (<0.0001);LAD (mm) 35.9±0.772 vs. 34.8±0.602 (0.215);LVDD (mm) 47.97±0.756 vs. 44.98±0.927(0.003);LVDS (mm) 29.85±0.897 vs. 26.68±0.681 (0.004);PW (mm) 11.86±0.270 vs. 10.92±0.208(0.002);IVS (mm) 12.12±0.348 vs. 10.95±0.253(0.002)。结论:在本研究中,观察到肾移植对心脏结构和功能的总体有利影响,LVH和LVMI以及左心室收缩和舒张功能显著降低,从而降低心血管事件相关死亡的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信